Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02830178 · ClinicalTrials.gov registry record
A Study of Channeling in the Use of Nonprescription Paracetamol and Ibuprofen in an Electronic Medical Records Database: Evidence and Implications
A clinical trial, sponsored by Janssen Research & Development.
- Completed
- Registry status
- 144,337
- Enrollment target
NCT02830178: Completed study, sponsored by Janssen Research & Development.
NCT02830178 is a clinical trial that has completed, run by Janssen Research & Development. The registered enrollment target is 144,337 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02830178 has completed, sponsored by Janssen Research & Development.
- COMPLETED
- Registry status
- 144,337 participants
- Enrollment target
Study Summary
The Purpose of this study is to examine whether evidence of channeling exists by analyzing within a cohort of participants with first prescriptions of single-ingredient paracetamol or ibuprofen (or both) whether participants with paracetamol were more likely to have an ibuprofen-related contraindication.
Primary Outcome
Participants receiving first prescriptions of single-ingredient paracetamol or ibuprofen will be assessed to analyze whether participants with paracetamol were more likely to have had an ibuprofen-related contraindication than participants with ibuprofen.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144,337 participants |
| Start Date | 2016-01 |
| Est. Completion | 2016-09 |
What the finished NCT02830178 record still lists
NCT02830178 is an observational study that tracks outcomes without assigning an intervention. Its 144,337 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02830178 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02830178 about?
NCT02830178 is a clinical study titled "A Study of Channeling in the Use of Nonprescription Paracetamol and Ibuprofen in an Electronic Medical Records Database: Evidence and Implications". The Purpose of this study is to examine whether evidence of channeling exists by analyzing within a cohort of participants with first prescriptions of single-ingredient paracetamol or ibuprofen (or both) whether participants with paracetamol were more likely to have an ibuprofen-related contraindica...
What is the current status of trial NCT02830178?
This trial is currently completed. The enrollment target is 144,337 participants. The study started on 2016-01. Estimated completion is 2016-09.
Who is sponsoring clinical trial NCT02830178?
This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06232551 · 152,000 participants · NA
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
- NCT06917339 · 156,000 participants
Retrospective Analyses of TrakStar Database
- NCT05994482 · 130,000 participants
Surveillance Colonoscopy in Older Adults: The SurvOlderAdults Study
- NCT02693509 · 128,026 participants
Get With The Guidelines-Heart Failure Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia